RxDoctor Payments DataLook up a doctor →

Michael Koren, MD

Cardiovascular Disease · Gainesville, FLNPI 1083645782

Payments from drug & device makers

$31,004,846in general payments, 2019–2025

Across 2,061 payments — averaging $15,044 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$15.5M
  • Astrazeneca UK Limited$4.5M
  • Pfizer$2.5M
  • Novartis$2M
  • AstraZeneca$1.8M
  • Amgen$1.5M
  • plus $3.2M from 40 others
$72,595in research payments, 2019–2025

Across 21 payments — averaging $3456.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$45K
  • Novartis$16K
  • Regeneron$7K
  • Pfizer$3K
  • Novo Nordisk AS$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$31,004,846 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Medicare billing

Part B allowed, 2024
$62,293
Medicare patients
208
Services billed
694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →